glutamine has been researched along with Agnogenic Myeloid Metaplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barosi, G; Campanelli, R; Catarsi, P; Massa, M; Poletto, V; Rosti, V; Vannucchi, AM; Villani, L | 1 |
| Beutler, E; Blume, KG; Paniker, NV | 1 |
2 other study(ies) available for glutamine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.
Topics: Cell Transformation, Neoplastic; Cohort Studies; Genetic Variation; Glutamine; Humans; Leukemia, Myeloid, Acute; Lysine; Phenotype; Polymorphism, Genetic; Primary Myelofibrosis; Xeroderma Pigmentosum Group D Protein | 2013 |
Enzymes of glutathione synthesis in patients with myeloproliferative disorders.
Topics: Acute Disease; Cysteine; Erythrocytes; Glutamine; Glutathione; Humans; Kinetics; Leukemia; Leukemia, Myeloid; Myeloproliferative Disorders; Peptide Synthases; Polycythemia Vera; Primary Myelofibrosis | 1973 |